Search results
Results from the WOW.Com Content Network
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...
Regeneron (REGN) closed the most recent trading day at $467.95, moving -0.57% from the previous trading session.
Regeneron (REGN) closed at $594.90 in the latest trading session, marking a -0.28% move from the prior day.
Regeneron has a robust business that has allowed it to get to the position where it is today, where a stock split could be a justifiable move. But ultimately, it depends on management and whether ...
In the latest trading session, Regeneron (REGN) closed at $630.31, marking a -1.13% move from the previous day.
Regeneron Pharmaceuticals (REGN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes. Regeneron Pharmaceuticals (REGN) Jumps: Stock Rises 6.3% Skip to main ...
On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending ...
Yahoo Finance Live examines Regeneron Pharmaceuticals' stock following reports of positive results in its eye treatment drug trials.